A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma: Japan Clinical Oncology Group Study 9002-Reference-Cited by-同舟云学术

A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma: Japan Clinical Oncology Group Study 9002

Published:2004-11-01 Issue:4 Volume:80 Page:341-350
ISSN:0925-5710
Container-title:International Journal of Hematology
language:
Short-container-title:International Journal of Hematology

Author:

Kinoshita Tomohiro,Hotta Tomomitsu,Tobinai Kensei,Kobayashi Tohru,Ishizuka Naoki,Tomonaga Masao,Sai Toshiaki,Ohno Youichiro,Kasai Masaharu,Ogura Michinori,Mikuni Chikara,Toki Hironobu,Sano Masayuki,Masaki Yasufumi,Ohtsu Tomoko,Matsuno Yoshihiro,Takenaka Takeaki,Shirakawa Shigeru,Shimoyama Masanori

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://www.springerlink.com/index/pdf/10.1532/IJH97.04085

Reference44 articles.

1. Armitage JO. Treatment of non-Hodgkin's lymphoma. N Engl J Med. 1993;328:1023-1030.

2. Shipp MA, Harrington DP, Klatt MM, et al. Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. Ann Intern Med. 1985;104:757-765.

3. Longo DL, DeVita VT Jr, Duffey PL, et al. Superiority of Pro-MACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. J Clin Oncol. 1991;9:25-38.

4. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. Ann Intern Med. 1985;102:596-602.

5. Gordon LI, Harrington D, Andersen J, et al. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. N Engl J Med. 1992;327:1342-1349.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A;Journal of Clinical and Experimental Hematopathology;2021

2. Dysnatremias in cancer;Onco-Nephrology;2020

3. Different dosage schedules for reducing cardiotoxicity in people with cancer receiving anthracycline chemotherapy;Cochrane Database of Systematic Reviews;2016-03-03

4. Extranodal natural killer/T-cell lymphoma from skin or soft tissue: suggestion of treatment from multinational retrospective analysis;Annals of Oncology;2012-10

5. Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low–intermediate risk, aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508;International Journal of Hematology;2012-06-03